{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:01:21Z","timestamp":1769180481114,"version":"3.49.0"},"reference-count":36,"publisher":"European Publishing","issue":"December","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tobaccoinduceddiseases.org"],"crossmark-restriction":false},"short-container-title":["Tob. Induc. Dis."],"DOI":"10.18332\/tid\/209827","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:59:21Z","timestamp":1765490361000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.18332\/tid\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Cross-sectional comparison of sociodemographic and tobacco use characteristics of US adults who regularly use products of leading electronic nicotine delivery systems (ENDS)"],"prefix":"10.18332","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-9491","authenticated-orcid":true,"given":"Amy L.","family":"Nyman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-8648","authenticated-orcid":false,"given":"Katherine C.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-4266","authenticated-orcid":false,"given":"Jeffrey","family":"Holland Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-5893","authenticated-orcid":false,"given":"David","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-5661","authenticated-orcid":false,"given":"Claire A.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-9155","authenticated-orcid":false,"given":"Jidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-4041","authenticated-orcid":false,"given":"Scott R.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7717","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"ref-1510194","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7218a1"},{"key":"ref-1510195","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102905"},{"key":"ref-1510196","unstructured":"King B. A year in review: FDA's progress on tobacco product regulation in 2024. U.S. Food & Drug Administration. Accessed June 26, 2025. https:\/\/www.fda.gov\/tobacco-products\/ctp-newsroom\/year-review-fdas-progress-tobacco-product-regulation-2024"},{"key":"ref-1510197","unstructured":"U.S. Food & Drug Administration. Premarket tobacco product applications. U.S. Food & Drug Administration. 2024. Accessed November 12, 2024. https:\/\/www.fda.gov\/tobacco-products\/market-and-distribute-tobacco-product\/premarket-tobacco-product-applications#1"},{"key":"ref-1510198","unstructured":"Deliso M. FDA reverses order taking Juul vaping products off the market in US, opens door to possible authorization. ABC News. June 6, 2024. Accessed October 7, 2024. https:\/\/abcnews.go.com\/Health\/fda-reverses-juul-marketing-ban\/story?id=110900909"},{"key":"ref-1510199","unstructured":"U.S. Food & Drug Administration. FDA authorized e-cigarette products. U.S. Food & Drug Administration. July 2025. Accessed August 20, 2025. https:\/\/digitalmedia.hhs.gov\/tobacco\/print_materials\/CTP-250?locale=en"},{"key":"ref-1510200","unstructured":"Goldman Sachs. Americas Tobacco: NielsenIQ Data thru 11\/16: Total nicotine sales declines ease led by cigs. November 26, 2024 2024."},{"key":"ref-1510201","unstructured":"Healio. FDA denies authorization to market Juul vaping products. https:\/\/www.healio.com\/news\/pulmonology\/20220623\/fda-denies-authorization-to-market-juul-vaping-products. Published 2022. Accessed October 8, 2024."},{"key":"ref-1510202","unstructured":"U.S. Food & Drug Administration. Update on FDA's Scientific review of Juul product applications. U.S. Food & Drug Administration. June 6, 2024. Accessed December 11, 2024. https:\/\/www.fda.gov\/tobacco-products\/ctp-newsroom\/update-fdas-scientific-review-juul-product-applications"},{"key":"ref-1510203","unstructured":"U.S. Food & Drug Administration. FDA authorizes marketing of tobacco- and menthol-flavored Juul e-cigarette products. U.S. Food & Drug Administration. 2025. Accessed August 23, 2025. https:\/\/www.fda.gov\/tobacco-products\/ctp-newsroom\/fda-authorizes-marketing-tobacco-and-menthol-flavored-juul-e-cigarette-products"},{"key":"ref-1510204","unstructured":"Goldman Sachs. Americas Tobacco: Nielsen Data thru 4\/9: Total nicotine volume declines accelerate lapping sharp Covid-related volatility. April 19, 2022 2022."},{"key":"ref-1510205","unstructured":"U.S. Food & Drug Administration. Tobacco products marketing orders. U.S. Food & Drug Administration. August 19, 2025. Accessed August 23, 2025. https:\/\/www.fda.gov\/tobacco-products\/market-and-distribute-tobacco-product\/tobacco-products-marketing-orders"},{"key":"ref-1510206","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae174"},{"key":"ref-1510207","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-023-01200-0"},{"key":"ref-1510208","unstructured":"Florko N. Juul spent big to court Black leaders to promote its e-cigarettes, new documents show. STAT. February 3, 2024. Accessed December 11, 2024. https:\/\/www.statnews.com\/2024\/02\/03\/juul-courting-black-leaders-promote-e-cigarettes\/"},{"key":"ref-1510209","doi-asserted-by":"publisher","DOI":"10.3390\/children11040465"},{"key":"ref-1510210","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.03.015"},{"key":"ref-1510211","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2019-055313"},{"key":"ref-1510212","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5502"},{"key":"ref-1510213","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6326"},{"key":"ref-1510214","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntad086"},{"key":"ref-1510215","doi-asserted-by":"publisher","DOI":"10.2196\/60184"},{"key":"ref-1510216","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291702006074"},{"key":"ref-1510217","unstructured":"U.S. Food & Drug Administration. FDA authorizes marketing of vuse alto tobacco-flavored e-cigarette pods and accompanying power unit. U.S. Food & Drug Administration. July 18, 2024. Accessed October 7, 2024. https:\/\/www.fda.gov\/tobacco-products\/ctp-newsroom\/fda-authorizes-marketing-vuse-alto-tobacco-flavored-e-cigarette-pods-and-accompanying-power-unit"},{"key":"ref-1510218","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz005"},{"key":"ref-1510219","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101750"},{"key":"ref-1510220","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102142"},{"key":"ref-1510221","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40880"},{"key":"ref-1510222","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107037"},{"key":"ref-1510223","doi-asserted-by":"publisher","DOI":"10.1111\/add.14936"},{"key":"ref-1510224","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.5436"},{"key":"ref-1510225","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054693"},{"key":"ref-1510226","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty237"},{"key":"ref-1510227","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6806e1"},{"key":"ref-1510228","unstructured":"U.S. Food & Drug Administration. FDA finalizes enforcement policy on unauthorized flavored cartridge-based e-cigarettes that appeal to children, including fruit and mint. PR Newswire. 2020. Accessed November 13, 2024. https:\/\/www.prnewswire.com\/news-releases\/fda-finalizes-enforcement-policy-on-unauthorized-flavored-cartridge-based-e-cigarettes-that-appeal-to-children-including-fruit-and-mint-300980613.html"},{"key":"ref-1510229","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2024.2392517"}],"container-title":["Tobacco Induced Diseases"],"original-title":[],"link":[{"URL":"https:\/\/www.tobaccoinduceddiseases.org\/pdf-209827-133170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tobaccoinduceddiseases.org\/pdf-209827-133170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:59:23Z","timestamp":1765490363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tobaccoinduceddiseases.org\/Cross-sectional-comparison-of-sociodemographic-and-tobacco-use-characteristics-of,209827,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":36,"journal-issue":{"issue":"December","published-online":{"date-parts":[[2025]]}},"alternative-id":["209827"],"URL":"https:\/\/doi.org\/10.18332\/tid\/209827","relation":{},"ISSN":["1617-9625"],"issn-type":[{"value":"1617-9625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"Research paper","name":"content_type","label":"Content type","group":{"name":"content_type"}},{"value":"Yes","name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer review"}},{"value":"Double blind","name":"review_process","label":"Review Process","group":{"name":"peer_review","label":"Peer review"}},{"value":"10 July 2025","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication history"}},{"value":"26 August 2025","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication history"}},{"value":"11 December 2025","name":"published","label":"Published","group":{"name":"publication_history","label":"Publication history"}},{"value":"\u00a9 2025 Nyman et al.","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and licensing"}},{"value":"This is an open access article distributed under the Creative Commons Attribution License (CC\u2011BY\u00a04.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and its authors credited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},"group":{"name":"copyright_and_licensing","label":"Copyright and licensing"}}]}}